Adjuvant Trastuzumab in HER2-Positive Breast Cancer

New England Journal of Medicine - Tập 365 Số 14 - Trang 1273-1283 - 2011
Dennis J. Slamon1, W. Eiermann2, Nicholas J. Robert3, Tadeusz Pieńkowski4, Miguel Martín5, Michael F. Press6,7, John R. Mackey8, John A. Glaspy1, Arlene Chan9, Marek Pawlicki6,7, Tamás Pintér10, Vicente Valero11, Mei-Ching Liu12, Guido Sauter13, Gϋnter von Minckwitz14, Fran Visco15, Valerie Bée16, Marc Buyse17, Belguendouz Bendahmane18, Isabelle Tabah-Fisch18, Mary-Ann Lindsay16, A. Riva16, John Crown19
1Jonsson Comprehensive Cancer Center, University of California–Los Angeles
2Frauenklinik vom Roten Kreuz, Munich
3U.S. Oncology Research
4Maria Sklodowska-Curie Center, Warsaw, Poland
5Hospital Universitario San Carlos, Madrid
6City Oncology Dispensary, St. Petersburg, Russia
7Norris Comprehensive Cancer Center, University of Southern California
8Department of Oncology, University of Alberta, Edmonton, Canada
9Mount Breast Group, Mount Hospital, Perth, Australia
10Petz Oktato Korhaz Onkoradiologia, Budapest, Hungary
11UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER
12Sun Yat Sen Cancer Center, Taipei, Taiwan
13Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg
14Zentrum für Frauenheilkunde, Frankfurt
15National Breast Cancer Coalition, Washington, DC
16Breast Cancer International Research Group
17International Drug Development Institute, Louvain-la-Neuve, Belgium
18Sanofi-Aventis,
19All Ireland Cooperative Oncology Research Group, St. Vincent's University Hospital, Dublin

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1038/35052073

10.1126/science.3798106

10.1126/science.2470152

Arboleda MJ, 2003, Cancer Res, 63, 196

10.1007/BF01961241

10.1002/jcp.21260

10.1016/j.yexcr.2008.10.034

10.1038/416279b

10.1007/s10911-008-9087-3

Pietras RJ, 1995, Oncogene, 10, 2435

10.1371/journal.pone.0003065

10.1128/MCB.9.3.1165

Hancock MC, 1991, Cancer Res, 51, 4575

Pegram MD, 1999, Semin Oncol, 26, 89

Pietras RJ, 1994, Oncogene, 9, 1829

10.1073/pnas.89.10.4285

10.1093/jnci/djh133

10.1200/JCO.2005.04.1764

10.1200/JCO.2004.06.557

10.1056/NEJM200103153441101

10.1056/NEJMoa052306

10.1056/NEJMoa052122

10.1056/NEJMoa053028

10.1016/S0140-6736(07)60028-2

10.1200/JCO.2005.02.4091

10.1038/sj.onc.1202526

10.1093/jnci/djh131

Pegram M, 2007, J Clin Oncol, 25, 964s, 10.1200/jco.2007.25.18_suppl.lba1008

10.1200/JCO.2009.27.5644

10.1093/jnci/djp067

10.1093/jnci/djp092

10.1056/NEJMoa021967

10.1016/S0140-6736(98)03301-7

10.1200/JCO.2005.11.012

10.1056/NEJM199405053301802

10.1093/jnci/90.18.1361

10.1093/jnci/92.24.1991

10.1056/NEJMoa054504

10.1093/jnci/djm252

10.1200/JCO.2005.02.5841

10.1200/JCO.2006.10.4976

10.1093/jnci/djk028

Thông tin
Thông tin xuất bản

New England Journal of Medicine

Tập 365 Số 14

1273-1283

Thông tin tác giả